Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Global Leishmaniasis Treatment Market Is Expected to Reach USD 223.88 million by 2027 : Fior Markets
2 Flow cytometry in neglected tropical diseases – a focus on leishmaniasis
3 Something old, something new combine for effective vaccine against parasitic skin disease
4 Leishmaniasis Treatment Market 2020: Size, share, Global Industry Trends, Growth Drivers, Business Opportunities and Demand Forecast to 2027
5 Keratitis occurring in patients treated with miltefosine for post-kala-azar dermal leishmaniasis
6 Chad: Quick Alerts
7 Insecticide spraying and awareness campaign on the Leishmaniasis disease in Idlib countryside
8 CBD For Leishmaniasis: What Does The Science Say?
9 Victory Square Technologies Portfolio Company Acquires Brazilian Manufacturing & Laboratory Facility to Increase Production of its Covid-19 Testing Products by an additional 4,000,000 Units in Bra
10 Leishmaniasis Treatment Market | Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2026
11 Global Leishmaniasis Treatment Market 2020 Industry Status
12 Leishmania infection and blood sources analysis in Phlebotomus chinensis (Diptera: Psychodidae) along extension region of the loess plateau, China
13 Global Leishmaniasis Treatment Market 2020 Report Reviews on Leading Competitors, Growth Trends, Future Prospects and Business Revenue Forecast to 2027
14 Cutaneous Leishmaniasis Drugs Market 2020 Size, Future Demand, Global Research, Top Leading player, Emerging Trends, Region by Forecast to 2027
15 CBD For Gallbladder: What Does The Science Say?
16 Cases of Leishmaniasis Increasing in the United States, Vaccine in Development
17 Emerging parasitic disease mimics the symptoms of visceral leishmaniasis in people
18 Call For Inorganic Expansion To Record A CAGR Of 3.3% In The Cutaneous And Systemic Leishmaniasis Market Between 2028
19 Study uncovers cause of aggressive leishmaniasis strain
20 European bats discovered as hosts for leishmaniasis infection
21 Leishmaniasis Treatment Market To Reach USD 224.67 Million by 2027
22 Hygienic housing key to eliminating visceral leishmaniasis
23 Study Uncovers Genetic Factors Behind Leishmaniasis Outcomes
24 A study investigating genetic mechanisms underlying resistance to leishmaniasis
25 Leishmaniasis
26 Predicting treatment outcome for leishmaniasis
27 Mobile clinics to restore medical reality in rebel-held northern Syria
28 New leishmaniasis look-alike parasitic infection reported
29 Expanding research capacity into neglected tropical diseases
30 Leishmaniasis in Kenya: Dozens of new cases reported
31 Case of Cutaneous Leishmaniasis reported in NEJM
32 Strenuous efforts to curb “leishmaniasis” northern Syria
33 Novartis, DNDi to jointly develop LXE408 for visceral leishmaniasis
34 M2-like, dermal macrophages are maintained via IL-4/CCL24–mediated cooperative interaction with eosinophils in cutaneous leishmaniasis
35 Leishmaniasis Treatment Market To Reach USD 206.5 Million by 2026 | Reports And Data
36 Leishmaniasis spread in the Middle East during war and conflict
37 Leishmaniasis needs more attention: it causes skin lesions, and can kill
38 Novartis and DNDi to jointly develop a new oral drug to treat visceral leishmaniasis
39 'Terrible condition does not even explain it'
40 Get Your Dog Vaccinated Against Leishmaniasis If You Live In Spain
41 Natural compound 2HF treats leishmaniasis infections, study finds
42 Kenya leishmaniasis update: Two dozen cases reported in past week
43 Leishmaniasis causes skin lesions, and is often lethal
44 WHO | WHO addressing leishmaniasis in high-risk areas of the Syrian Arab Republic
45 WHO provides support for treatment of leishmaniasis in Libya
46 Hit-to-lead in neglected diseases – it's a numbers game
47 Rare Parasitic Infection 'Leishmaniasis' Rising in the US
48 Visceral Leishmaniasis Market 2020-2027 Size, Trends, Analysis, Demand, Outlook || Leading Players – Avet Pharmaceuticals Inc, Astellas Pharma Inc, Fresenius Kabi AG, Seton Pharmaceuticals
49 Investigators Use Innovative Approach to Explore New Treatment Options for Leishmaniasis
50 The Little-Known, Disfiguring Disease That's Coming Our Way
51 Kala azar (visceral leishmaniasis) | MSF UK | Médecins Sans Frontières UK
52 Victory Square Health Announces Update to Previous News Release
53 How does the body respond to diffuse cutaneous leishmaniasis?
54 WHO warns of leishmaniasis outbreak in KP in February
55 How visceral leishmaniasis spread through central-Southern Brazil
56 Asymptomatic visceral leishmaniasis prevalent in US soldiers deployed to Iraq
57 Topical cream found as less-toxic therapy to treat cutaneous leishmaniasis
58 Dormant leishmaniasis parasites: threat to control
59 Eliminating visceral leishmaniasis in South Asia: the road ahead
60 Skin plays significant role in spread of leishmaniasis
61 Kala azar
62 Global health researcher helps build treatment center in Kenya to combat neglected tropical disease visceral leishmaniasis
63 Cutaneous leishmaniasis emerging among refugees in Lebanon
64 Discovery of a new potential treatment for visceral leishmaniasis
65 Can we treat leishmaniasis with tiny magnets?
66 Nanodrug tames leishmaniasis and other parasitic diseases
67 Visceral leishmaniasis on the rise in Brazil, study finds
68 Easy sweat-based test for leishmaniasis
69 New strains of leishmaniasis may hit elimination plans
70 Three tropical diseases targeted in push for new drugs
71 Patients treated for visceral leishmaniasis can still transmit the disease, study shows
72 UI study finds vaccine effective in treating leishmaniasis in dogs, could reduce its spread to humans
73 Leishmaniasis breaks the equilibrium
74 Kenya: Four Leishmaniasis deaths reported in Kitui County, Kenya
75 Leishmaniasis: Genes key to identifying drug resistant parasites in Brazil
76 WHO addressing leishmaniasis in high-risk areas of Syrian Arab Republic
77 Visceral leishmaniasis diagnostic tests
78 Treatment for canine leishmaniasis exists in Brazilian vaccine
79 Quantitative proteomics reveals a broad‐spectrum antiviral property of ivermectin, benefiting for COVID‐19 treatment
80 Leishmaniasis| A Pipeline Analysis Report 2018| Technavio
81 Leishmaniasis infection on the rise in US ecotourists, soldiers
82 INST develops oral nanomedicine for combating visceral leishmaniasis
83 Dog fleas implicated in leishmaniasis spread
84 Danger in the rubble: fighting leishmaniasis in Syria | Syria-news | Syrian Arab Republic
85 GHIT Fund Announces New Investments: A Total of 3.29 Billion Yen in Drugs for Malaria, Tuberculosis, Chagas Disease, Lymphatic Filariasis, and Onchocerciasis, Vaccines for Malaria, and Diagnostics for Leishmaniasis and Mycetoma
86 Research identifies potential targets for treatment of leishmaniasis
87 Sand fly mating habits offer way to tackle tropical disease
88 Leishmaniasis outbreak in northwest Libya town
89 As 'Flesh-Eating' Leishmania Come Closer, a Vaccine Against Them Does, Too
90 Leishmaniasis strain in Iraq outbreak identified
91 Leishmaniasis: Getting under the skin of parasitic disease
92 Leishmaniasis in humans: drug or vaccine therapy? | DDDT
93 Combination therapy more effective in treating patients with leishmaniasis and HIV
94 The only option for cutaneous leishmaniasis treatment | Pakistan | MSF
95 Leishmaniasis spreads rapidly in Deir Ezzor infecting hundreds of children
96 How Wikipedia’s Project SWASTHA is fighting the India Covid-19 infodemic
97 Two combined drugs effective against HIV-leishmaniasis
98 Plant Used In Traditional Mayan Medicine Holds Potential Leishmaniasis Treatment
99 Traditional Medicine for Leishmaniasis
100 Paromomycin Topical Cream Effective in Treating Cutaneous Leishmaniasis